| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-03-19 | Chu Yu-Waye Chief Medical Officer | Sale | -21,279 | -10.10%189,446 | $6.42 | $136,675 | View SEC filing | |
| 2026-03-19 | McCarthy Sean A. CEO | Sale | -118,969 | -9.93%1,078,922 | $6.42 | $764,138 | View SEC filing | |
| 2026-03-19 | BELVIN MARCIA SVP, Chief Scientific Officer | Sale | -31,492 | -9.48%300,760 | $6.42 | $202,273 | View SEC filing | |
| 2026-03-19 | Ogden Christopher Chief Financial Officer | Sale | -19,323 | -6.11%296,948 | $6.42 | $124,112 | View SEC filing | |
| 2025-11-10 | McCarthy Sean A. CEO | Sale | -101,793 | -9.34%987,891 | $4.54 | $461,906 | View SEC filing | |
| 2025-06-17 | Ogden Christopher Chief Financial Officer | Sale | -12,255 | +12.56%226,271 | $2.72 | $33,381 | View SEC filing | |
| 2025-06-17 | BELVIN MARCIA SVP, Chief Scientific Officer | Sale | -13,884 | -4.85%272,252 | $2.69 | $37,334 | View SEC filing | |
| 2025-06-17 | McCarthy Sean A. CEO | Sale | -55,511 | -4.85%1,089,684 | $2.69 | $149,264 | View SEC filing | |
| 2025-03-20 | McCarthy Sean A. CEO | Sale | -37,656 | -3.65%995,195 | $0.60 | $22,556 | View SEC filing | |
| 2025-03-20 | Ogden Christopher Chief Financial Officer | Sale | -8,551 | -4.08%201,026 | $0.60 | $5,122 | View SEC filing | |
| 2025-03-20 | Chu Yu-Waye Chief Medical Officer | Sale | -4,025 | -2.88%135,725 | $0.60 | $2,411 | View SEC filing | |
| 2025-03-20 | ROWLAND LLOYD A General Counsel | Sale | -10,203 | -7.80%120,594 | $0.60 | $6,112 | View SEC filing | |
| 2025-03-20 | BELVIN MARCIA SVP, Chief Scientific Officer | Sale | -19,512 | -7.28%248,636 | $0.60 | $11,688 | View SEC filing | |
| 2024-08-22 | Landau Jeffrey B Chief Business Officer | Sale | -4,181 | -3.39%119,056 | $1.23 | $5,139 | View SEC filing | |
| 2024-08-22 | BELVIN MARCIA SVP, Chief Scientific Officer | Sale | -4,181 | -2.32%175,648 | $1.23 | $5,139 | View SEC filing | |
| 2024-08-22 | ROWLAND LLOYD A General Counsel | Sale | -4,181 | -3.10%130,797 | $1.23 | $5,139 | View SEC filing | |
| 2024-08-22 | Ogden Christopher Chief Financial Officer | Sale | -1,984 | -1.80%108,077 | $1.23 | $2,439 | View SEC filing | |
| 2024-08-22 | McCarthy Sean A. CEO | Sale | -13,898 | -2.07%657,851 | $1.23 | $17,082 | View SEC filing | |
| 2024-03-21 | ROWLAND LLOYD A General Counsel | Sale | -5,268 | -4.28%117,728 | $2.09 | $10,986 | View SEC filing | |
| 2024-03-21 | McCarthy Sean A. CEO | Sale | -20,223 | -3.71%524,481 | $2.09 | $42,175 | View SEC filing | |
| 2024-03-21 | Ogden Christopher SVP, Finance and Accounting | Sale | -2,971 | -3.35%85,686 | $2.09 | $6,196 | View SEC filing | |
| 2024-03-21 | BELVIN MARCIA SVP, Chief Scientific Officer | Sale | -12,795 | -7.05%168,579 | $2.09 | $26,684 | View SEC filing | |
| 2024-03-21 | Landau Jeffrey B Chief Business Officer | Sale | -6,562 | -5.63%110,060 | $2.09 | $13,685 | View SEC filing | |
| 2023-12-22 | McCarthy Sean A. CEO | Sale | -13,551 | -2.89%454,704 | $1.38 | $18,710 | View SEC filing | |
| 2023-12-22 | BELVIN MARCIA SVP, Chief Scientific Officer | Sale | -4,077 | -2.56%155,124 | $1.38 | $5,628 | View SEC filing |
1-25 of 143
